Assessing the potential of a candidate dengue vaccine with mathematical modeling

PLoS Neglected Tropical Diseases

Volumn 6, Issue 3, 2012, Pages

  WHO VMI Dengue Vaccine Modeling Group, ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE;

ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; DENGUE; DISEASE CONTROL; DISEASE TRANSMISSION; HUMAN; IMMUNE RESPONSE; MATHEMATICAL MODEL; VACCINATION; IMMUNOLOGY; STATISTICAL MODEL;

DENGUE; DENGUE VACCINES; HUMANS; MODELS, STATISTICAL;

EID: 84859201235     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001450     Document Type: Article

References (79)

1. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
2. Halstead SB, (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476.
3. Whitehorn J, Farrar J, (2010) Dengue. Brit Med Bul 95: 161-173.
4. Gubler DJ, (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 10: 100-103.
5. Beatty ME, Beutels P, Meltzer MI, Shepard DS, Hombach J, et al. (2011) Health economics of dengue: a systematic literature review and expert panel's assessment. Am J Trop Med Hyg 84: 473-478.
6. da Silva-Nunes M, de Souza VAF, Pannuti CS, Sperança MA, Terzian ACB, et al. (2008) Risk factors for dengue virus infection in rural Amazonia: population-based cross-sectional surveys. Am J Trop Med Hyg 79: 485-494.
7. Halstead SB, (1980) Dengue haemorrhagic fever- a public health problem and a field of research. Bull World Health Org 58: 1-21.
8. Pandey BD, Rai SK, Morita K, Kurane I, (2004) First case of Dengue virus infection in Nepal. Nepal Med Coll J 6: 157-159.
9. CDC (2010) Morbidity and mortality weekly report. MMWR Morb Mortal Wkly Rep 59: 577-581.
10. US Centers for Disease Control (2011) DengueMap: a CDC-HealthMap collaboration. Available: http://www.healthmap.org/dengue/index.php. Accessed 24 February 2012.
11. Gubler DJ, (1998) Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11: 480-496.
12. Gubler DJ, Meltzer M, (1999) The impact of dengue/dengue hemorrhagic fever on the developing world. Adv Virus Res 53: 35-70.
13. Sabin A, (1952) Research on dengue during World War II. Am J Trop Med Hyg 1: 30-50.
14. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM, (2010) Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 10: 712-722.
15. Halstead SB, (1979) In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 140: 527-533.
16. Rothman AL, (2004) Dengue: defining protective versus pathologic immunity. J Clin Invest 113: 946-951.
17. Guy B, Almond J, Lang J, (2011) Dengue vaccine prospects: a step forward. Lancet 377: 381-382.
18. Guy B, (2009) Immunogenicity of sanofi pasteur tetravalent dengue vaccine. J Clin Virol 46 (Suppl 2): S16-S19.
19. Guy B, Saville M, Lang J, (2010) Development of Sanofi Pasteur tetravalent dengue vaccine. Human Vaccines 6: 696-705.
20. Hombach J, (2009) Guidelines for clinical trials of dengue vaccine in endemic areas. J Clin Virol 46 (Suppl 2): S7-S9.
21. Lang J, (2009) Recent progress on sanofi pasteur's dengue vaccine candidate. J Clin Virol 46: S20-S24.
22. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
23. Stephenson JR, (2005) Understanding dengue pathogenesis: implications for vaccine design. Bull World Health Org 83: 308-314.
24. WHO (2011) Report of the meeting of the WHO/VMI Workshop on Dengue modeling Geneva World Health Organization. WHO/IVB/11.02.
25. WHO (2005) Vaccine introduction guidelines. Adding a vaccine to national immunization programme: decision and implementation Geneva World Health Organization. WHO/IVB/05.18.
26. Focks DA, Daniels E, Haile DG, Keesling JE, (1995) A simulation model of the epidemiology of urban dengue fever: literature analysis, model development, preliminary validation, and samples of simulation results. Am J Trop Med Hyg 53: 489-506.
27. Ferguson NM, Donnelly CA, Anderson RM, (1999) Transmission dynamics and epidemiology of dengue: insights from age-stratified sero-prevalence surveys. Phil Trans R Soc Lond B 354: 757-768.
28. Cummings DAT, Schwartz IB, Billings L, Shaw LB, Burke DS, (2005) Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A 102: 15259-15264.
29. Wearing HJ, Rohani P, (2006) Ecological and immunological determinants of dengue epidemics. Proc Natl Acad Sci U S A 103: 11802-11807.
30. Recker M, Blyuss KB, Simmons CP, Hien TT, Wills B, et al. (2009) Immunological serotype interactions and their effect on the epidemiological pattern of dengue. Proc R Soc Lond B 276: 2541-2548.
31. Nagao Y, Koelle K, (2008) Decreases in dengue transmission may act to increase the incidence of dengue hemorrhagic fever. Proc Natl Acad Sci U S A 105: 2238-2243.
32. Cummings DAT, Iamsirithaworn S, Lessler JT, McDermott A, Prasanthong R, et al. (2009) The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med 6: e1000139 doi:10.1371/journal.pmed.1000139.
33. Wikramaratna PS, Simmons CP, Gupta S, Recker M, (2010) The effects of tertiary and quaternary infections on the epidemiology of dengue. PLoS ONE 5: e12347 doi:10.1371/journal.pone.0012347.
34. Lahiri M, Fisher D, Tambyah PA, (2008) Dengue mortality: reassessing the risks in transition countries. Trans R Soc Trop Med Hyg 102: 1011-1016.
35. Guzmán MG, Alvarez M, Rodríguez R, Rosario D, Vázquez S, et al. (1999) Fatal dengue hemorrhagic fever in Cuba, 1997. Intl J Infect Dis 3: 130-135.
36. Anders KL, Nguyet NM, Chau NVV, Hung NT, Thuy TT, et al. (2011) Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 84: 127-134.
37. Lipsitch M, Bergstrom CT, Levin BR, (2000) The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci U S A 97: 1938-1943.
38. Medlock J, Galvani AP, (2009) Optimizing Influenza Vaccine Distribution. Science 325: 1705-1708.
39. Boni MF, Smith DL, Laxminarayan R, (2008) Benefits of using multiple first-line therapies against malaria. Proc Natl Acad Sci U S A 105: 14216-14221.
40. Halstead SB, Rojanasuphot S, Sangkawibha N, (1983) Original Antigenic Sin in Dengue. Am J Trop Med Hyg 32: 154-156.
41. Mongkolsapaya J, Dejnirattisai W, Xu X-N, Vasanawathana S, Tangthawornchaikul N, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921-927.
42. Midgley CM, Bajwa-Joseph M, Vasanawathana S, Limpitikul W, Wills B, et al. (2011) An in-depth analysis of original antigenic sin in dengue virus infection. J Virol 85: 410-421.
43. Webster DP, Farrar J, Rowland-Jones S, (2009) Progress towards a dengue vaccine. Lancet Infect Dis 9: 678-687.
44. Guzmán MG, Kouri GP, Bravo J, Soler M, Vazquez S, et al. (1990) Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42: 179-184.
45. Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, et al. (1999) A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 61: 412-419.
46. Halstead SB, (2003) Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 60: 421-467.
47. Thein S, Aung MM, Shwe TN, Aye M, Zaw A, et al. (1997) Risk factors of dengue shock syndrome in children. Am J Trop Med Hyg 56: 566-572.
48. Halstead SB, (2008) Dengue virus-mosquito interactions. Annual Rev Entomol 53: 273-291.
49. Brown M, Klowden M, Crim J, Young L, Shrouder L, et al. (1994) Endogenous regulation of mosquito host-seeking behavior by a neuropeptide. J Insect Physiol 40: 399-406.
50. Platt KB, Linthicum KJ, Myint KS, Innis BL, Lerdthusnee K, et al. (1997) Impact of dengue virus infection on feeding behavior of Aedes aegypti. Am J Trop Med Hyg 57: 119-125.
51. Scott TW, Amerasinghe PH, Morrison AC, Lorenz LH, Clark GG, et al. (2000) Longitudinal studies of Aedes aegypti (Diptera: Culicidae) in Thailand and Puerto Rico: blood feeding frequency. J Med Entomol 37: 89-101.
52. Ball F, (1985) Deterministic and stochastic epidemics with several kinds of susceptibles. Adv Appl Prob 17: 1-22.
53. Anderson RM, Medley GF, May RM, Johnson AM, (1986) A preliminary study of the transmission dynamics of the human immunodeficiency virus (HIV), the causative agent of AIDS. IMA J Math Appl Med Biol 3: 229-263.
54. Rabaa MA, Ty Hang VT, Wills B, Farrar J, Simmons CP, et al. (2010) Phylogeography of recently emerged DENV-2 in Southern Viet Nam. PLoS Negl Trop Dis 4: e766 doi:10.1371/journal.pntd.0000766.
55. Raghwani J, Rambaut A, Holmes EC, Hang VT, Hien TT, et al. (2011) Endemic dengue associated with the co-circulation of multiple viral lineages and localized density-dependent transmission. PLoS Pathog 7: e1002064 doi:10.1371/journal.ppat.1002064.
56. Focks DA, Brenner RJ, Hayes J, Daniels E, (2000) Transmission thresholds for dengue in terms of Aedes aegypti pupae per person with discussion of their utility in source reduction efforts. Am J Trop Med Hyg 62: 11-18.
57. Shrestha S, King AA, Rohani P, (2011) Statistical inference for multi-pathogen systems. PLoS Comput Biol 7: e1002135 doi:10.1371/journal.pcbi.1002135.
58. Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, et al. (2000) Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol 152: 793-799.
59. Winter PE, Yuill TM, Suchinda U, Gould D, Nantapanich S, et al. (1968) An insular outbreak of dengue hemorrhagic fever. I. Epidemiologic observations. Am J Trop Med Hyg 17: 590-599.
60. Winter PE, Nantapanich S, Nisalak A, Udomsakdi S, Dewey RW, et al. (1969) Recurrence of epidemic dengue hemorrhagic fever in an insular setting. Am J Trop Med Hyg 18: 573-579.
61. Moreira La, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, et al. (2009) A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell 139: 1268-1278.
62. Thomas DD, Donnelly CA, Wood RJ, Alphey LS, (2000) Insect population control using a dominant, repressible, lethal genetic system. Science 287: 2474-2476.
63. Halstead SB, Scanlon JE, Umpaivit P, Udomsakdi S, (1969) Dengue and Chikungunya virus infection in man in Thailand, 1962-1964. IV. Epidemiologic studies in the Bangkok metropolitan area. Am J Trop Med Hyg 18: 997-1021.
64. Russell PK, Yuill TM, Nisalak AA, Udomsakdi S, Gould DJ, et al. (1968) An insular outbreak of dengue hemorrhagic fever. II. Virologic and serologic studies. Am J Trop Med Hyg 17: 600-608.
65. Burke DS, Nisalak A, Johnson DE, Scott RM, (1988) A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38: 172-180.
66. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, et al. (1984) Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120: 653-669.
67. Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, et al. (1999) Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever. Lancet 354: 1431-1434.
68. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (2000) Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181: 2-9.
69. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, et al. (1997) Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 176: 322-330.
70. Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, et al. (2007) Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 369: 1452-1459.
71. Endy TP, Yoon I-K, Mammen MP, (2010) Prospective cohort studies of dengue viral transmission and severity of disease. Curr Topics Microbiol Immunol 338: 1-13.
72. Endy TP, (2002) Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 156: 40-51.
73. Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, et al. (2005) Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg 72: 60-66.
74. Beckett CG, Kosasih H, Faisal I, Nurhayati, Tan R, et al. (2005) Early detection of dengue infections using cluster sampling around index cases. Am J Trop Med Hyg 72: 777-782.
75. Balmaseda A, Hammond SN, Tellez Y, Imhoff L, Rodriguez Y, et al. (2006) High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Intl Health 11: 935-942.
76. Tien NTK, Luxemburger C, Toan NT, Pollissard-Gadroy L, Huong VTQ, et al. (2010) A prospective cohort study of dengue infection in schoolchildren in Long Xuyen, Viet Nam. Trans R Soc Trop Med Hyg 104: 592-600.
77. Kuan G, Gordon A, Avilés W, Ortega O, Hammond SN, et al. (2009) The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 170: 120-129.
78. Balmaseda A, Standish K, Mercado JC, Matute JC, Tellez Y, et al. (2010) Trends in patterns of dengue transmission over 4 years in a pediatric cohort study in Nicaragua. J Infect Dis 201: 5-14.
79. Chau TNB, Hieu NT, Anders KL, Wolbers M, Lien LB, et al. (2009) Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants. J Infect Dis 200: 1893-1900.